Kristen Sanfilippo/X
Jun 22, 2025, 12:53
Kristen Sanfilippo: Time to Anticoagulants Therapy is a Modifiable Risk Factor for PE-associated Mortality
Kristen Sanfilippo, Hematologist in the Division of Hematology at Washington University School of Medicine, shared a post on X:
“Time to Anticoagulants therapy is a modifiable risk factor for PE-associated mortality.
- Big weekend for Kelsey Bria
- Finished Residency
- Started Fellowship as our newest ASH HFFTP
- First Oral “
More posts from ISTH 2025 on Hemostasis Today.
-
Jan 14, 2026, 05:56Arun V J on The “Whole Blood” Nostalgia Trap
-
Jan 13, 2026, 16:38Caitlin Raymond: Understanding TAMOF as a TTP-Like Process
-
Jan 13, 2026, 15:22John Amako: Childhood to Adulthood Management Approach for SCD
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings